美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物科技指数ETF-iShares Nasdaq

204.26

-2.2300-1.08%

盘后：204.260.00000.00%19:47 EDT

成交量：115.73万

成交额：2.37亿

市值：107.13亿

市盈率：32.36

高：206.93

开：206.85

低：203.92

收：206.49

52周最高：217.12

52周最低：149.09

股本：5,245.00万

流通股本：5,245.00万

量比：0.50

换手率：2.21%

股息：0.33

股息率：0.16%

每股收益(TTM):6.31

每股收益(LYR):35.34

净资产收益率：24.54%

总资产收益率：0.10%

市净率：1.32

市盈率(LYR):5.78

数据加载中...

总览公司新闻资讯公告

Ocular Therapeutix股价因竞争对手Kodiak在临床试验中获胜而暴跌，分析师称抛售反应过度

数据简报-美国制药企业纷纷转向中国寻求许可协议

科迪亚克科学公司股价上涨，因其眼部疾病药物达到临床试验目标

正大天晴与STADA达成生物类似药战略合作

罗氏：公司整理的分析师共识显示，预计到2030年生物类似药将造成62亿瑞士法郎的销售缺口。

美国食品药品监督管理局批准Mirum公司治疗罕见骨病的药物

健康快讯：基因研究成果为逆转阿尔茨海默病脑损伤提供了线索

安进一种自身免疫药物在后期临床试验达到主要目标

美国法官在夏威夷能源和解协议争议中主动回避

美国研究综述-Allstate、Autozone、Vertex Pharmaceuticals

安进(AMGN)股票9月22日盘中上涨3.90%：原因全解读

TradingKey中文

安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点

安进股价上涨，因其自身免疫疾病药物达到晚期临床试验目标

Vertex股价上涨，因其肾病药物在中期研究中展现出良好前景

数据简报-随着竞争日趋激烈，减肥药开发商纷纷抢占这一利润丰厚的市场

安进股价盘前大涨逾4%，受第三期临床试验结果提振。

福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果，第13周UACR显著降低42.7%

安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果

安进：Dazodalibep在系统性疾病活动方面展现出统计学显著且具有临床意义的改善

更正-安进的自身免疫性疾病药物在后期临床试验中取得成功

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/IBB/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指数ETF-iShares Nasdaq","latestPrice":204.26,"timestamp":1791835200000,"preClose":206.49,"halted":0,"volume":1157283,"hourTrading":{"tag":"盘后","latestPrice":204.26,"preClose":204.26,"latestTime":"19:47 EDT","volume":10034,"amount":2049515.9148,"timestamp":1791848828793,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010799554457843082,"floatShares":52450000,"shares":52450000,"eps":6.311863,"marketStatus":"未开盘","change":-2.23,"latestTime":"10-12 16:00:00 EDT","open":206.85,"high":206.93,"low":203.92,"amount":237090797.56701,"amplitude":0.014577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":206.49,"sharesOutstanding":49450000,"nav":206.296467,"aum":10840879340.85,"dividendRate":0.001618,"bidAskSpread":0.000349,"preHourTrading":{"tag":"盘前","latestPrice":206.5,"preClose":206.49,"latestTime":"09:27 EDT","volume":190,"amount":39274.1248,"timestamp":1791811645668,"change":0.01,"changeRate":0.000048,"amplitude":0.029869},"postHourTrading":{"tag":"盘后","latestPrice":204.26,"preClose":204.26,"latestTime":"19:47 EDT","volume":10034,"amount":2049515.9148,"timestamp":1791848828793,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.501392,"impliedVol":0.2474,"impliedVolPercentile":0.704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":52450000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.501392,"shares":52450000,"dividePrice":0.3304,"high":206.93,"amplitude":0.014577,"preClose":206.49,"low":203.92,"week52Low":149.0909,"pbRate":"1.32","psRate":"257.76","week52High":217.12,"institutionHeld":0,"latestPrice":204.26,"eps":6.311863,"divideRate":0.001618,"volume":1157283,"delay":0,"ttmEps":6.311863,"open":206.85,"prevYearClose":168.77,"prevWeekClose":206.49,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":207.96,"twentyDayClose":204.6,"sixtyDayClose":189.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671252936","title":"Ocular Therapeutix股价因竞争对手Kodiak在临床试验中获胜而暴跌，分析师称抛售反应过度","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252936?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620641,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix股价因竞争对手Kodiak在临床试验中获胜而暴跌，分析师称抛售反应过度9月28日-** Ocular Therapeutix（OCUL.O）股价在午后交易中下跌18.8%，至7.84美元** Kodiak Sciences公司（KOD.O）的实验性药物Zenkuda和tabirafusp-ted在针对湿性年龄相关性黄斑变性患者的后期临床试验中达到了主要","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4S45K1CI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","OCUL","BK4585","LU0823434583.USD","LU0823434740.USD","LU2237438978.USD","IBB","BK4505","IBBQ","KOD","BK4007","BBH","LU0889565916.HKD","LU1917777945.USD","LU2023250504.SGD","LU2106854487.HKD","LU0053666078.USD","TBXU","LU0058720904.USD","LU2089984988.USD","LU2362541513.USD","LU0109394709.USD","LU1974910355.USD","BK4139","LU2362540622.SGD","LU2362541273.HKD","BK4588","LU0823416689.USD","REGN","LU0882574055.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670555622","title":"数据简报-美国制药企业纷纷转向中国寻求许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2670555622","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670555622?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 22:32","pubTimestamp":1790605948,"startTime":"0","endTime":"0","summary":"数据简报-美国制药企业纷纷转向中国寻求许可协议路透9月28日-默克公司周一同意向中国生物技术公司  SciBrunch Therapeutics支付4亿美元预付款，以获得一种实验性抗癌药的全球权益，成为最新一家获得中国研发药物授权的美国制药商。中国生物技术公司通常会保留国内权益 ，并将药物授权给海外企业，以此换取预付款、里程碑付款以及专利使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4T45K134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","LU1069347547.HKD","LU2289578879.USD","LU2028103732.USD","LU0211327993.USD","SGXZ51526630.SGD","LU0912757837.SGD","SG9999017495.SGD","IYH","ELIS","LU2362541273.HKD","LU1496350171.SGD","BK0196","LU0057025933.USD","LU2328871848.SGD","LU1064131342.USD","BBH","LU0823434583.USD","LU2265009873.SGD","LU2360032135.SGD","IE00BFSS8Q28.SGD","LU0203201768.USD","LU1934455194.USD","SG9999013999.USD","SMMT","LU0289961442.SGD","LU1941712348.USD","LU0097036916.USD","LU0417516902.SGD","LU1093756168.USD","LU1868837300.USD","LU1929549753.HKD","LU2361044949.HKD","LU1699723380.USD","SG9999001176.SGD","LU2896262040.SGD","BK1574","LU1116320737.USD","LLII","LU2133065610.SGD","LU2125154778.USD","CANC","LU1868836757.USD","LU1244550577.SGD","LU0683600562.USD","PFE","LU2471134796.USD","LU2236285917.USD","IE0005OL40V9.USD","LU0417517546.SGD","LU1983299246.USD","IE00BK4W5M84.HKD","LU0823434740.USD","IE00BN29S564.USD","LU2023250330.USD","LU1585245621.USD","LU0345770993.USD","LU2462591350.SGD","LU0942090050.USD","LU2491050154.USD","VHT","IE000SO60NU8.SGD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","LU0267386448.USD","LU0306806265.USD","LU0289739699.SGD","TMED","LU2108987350.USD","SG9999014575.USD","LU0354030438.USD","LU1366192091.USD","IE00BN8TJ469.HKD","LU2242646821.SGD","LU0889565916.HKD","09926","LU2168564065.EUR","LU0456855351.SGD","LU2552382215.SGD","BK4532","IE00BVYPNW00.USD","LU1146622755.USD","LU2491050071.SGD","HK0000165453.HKD","LU0640476718.USD","IE00B3T34201.USD","LU2750360641.GBP","IE00BJJMRZ35.SGD","LU2097828474.EUR","LU2462157665.USD","IE00BKDWB100.SGD","LU1969619763.USD","IE00B4JS1V06.HKD","IBBQ","LU0079474960.USD","MHIP","LU0320765992.SGD","SG9999015952.SGD","BK4550","LU0348784397.USD","LU1820825898.SGD","LU1720051108.HKD","LU2168564222.USD","LU0320765646.SGD","LU0114720955.EUR","LU2089984988.USD","LU0985481810.HKD","LU0672654240.SGD","LU1732799900.SGD","LU2399975544.HKD","LU2168563687.JPY","PPH","BK0239","IE00B3PB1722.GBP","IE00BKPKM429.USD","BK4568","BK1589","LU0348783233.USD","LU0348767384.USD","IE00BDGV0183.EUR","LU2580892862.HKD","LU0726765562.USD","IE0002270589.USD","LU1093756325.SGD","BK4533","IE00BWXC8680.SGD","LU1035775433.USD","LU2271345857.HKD","ILDR","LU0321505439.SGD","LU0321505868.SGD","BK0183","LU0405327148.USD","LU2491049909.HKD","LLY","IE000F7OJYX1.SGD","LU1997245094.SGD","WDNA","LU1188198961.HKD","MEDI","LU2471134879.HKD","IE0004445239.USD","LU2129689431.USD","LU2112291526.USD","LU0943347566.SGD","LU0949170772.SGD","FHLC","LU0211331839.USD","BK4566","LU2362540622.SGD","LU0053666078.USD","LU1961090484.USD","LU2580892789.USD","LU2347655156.SGD","LU1267930573.SGD","SG9999015945.SGD","BK4592","LU1934455863.HKD","LU0348825331.USD","LU2361045086.USD","LU0203347892.USD","LU2106854487.HKD","LU2237443895.HKD","LU2023250504.SGD","LU1629891620.HKD","LU0634319403.HKD","IE00BGHQF631.EUR","LU0861579265.USD","LU0094547139.USD","LU2476274308.USD","LU1814569148.SGD","LU1670627923.USD","IE00B7KXQ091.USD","IE0002141913.USD","LU0237698245.USD","BK4534","GB00BDT5M118.USD","LU0708995401.HKD","LU2361044865.SGD","LU2237443978.SGD","LU1496350502.SGD","03692","LU0122379950.USD","LU2023250843.SGD","LU0417516738.SGD","LU1997245177.USD","SG9999003800.SGD","LU1066051225.USD","LU1236620834.HKD","LU0174119429.USD","LU2097828631.EUR","LU1201861249.SGD","IE000M9KFDE8.USD","IE0004445015.USD","LU1430594728.SGD","TRUH","LU0868494617.USD","LU0256863811.USD","LU0823416689.USD","LU1244550494.USD","LU0795875086.SGD","688331","LU0472753341.HKD","LU0417516571.SGD","LU1670711123.USD","LU0432979614.USD","LU1839511570.USD","LU1328615791.USD","LU1323610961.USD","BK4559","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","LU1670710661.SGD","IE000MB6IJN5.SGD","LU2471134952.CNY","LU0306807586.USD","SG9999002232.USD","LU2063271972.USD","PAWZ","LU0353189763.USD","LU1255011170.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","LU0786609619.USD","LU0310799852.SGD","LU0964807845.USD","LU0882574055.USD","LU0859254822.USD","BK1593","LU1571399168.USD","SG9999014880.SGD","LU2488822045.USD","LU1127390331.HKD","LU2264538146.SGD","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","SG9999015358.SGD","LU0965508806.USD","LU0234570918.USD","IE00BPRC5H50.USD","ELIL","BK0060","LU2125154935.USD","SG9999015986.USD","LU1868836914.USD","LU2746668974.SGD","LU0385154629.USD","LU0058720904.USD","09995","LU2087621335.USD","LU0820562030.AUD","LU0133085943.USD","LU0130102774.USD","LU1868837136.USD","LU2168564149.EUR","LU2456880835.USD","BK4007","BK4585","LU0463099449.HKD","LU2433249047.HKD","LU0096364046.USD","LU0225771236.USD","LU1670711040.USD","GDOC","BK4516","LU1732800096.USD","IE00BBT3K403.USD","LU1291159041.SGD","LU2148510915.USD","LU2746668461.USD","IHE","BK1161","LU0158827781.USD","LU0511384066.AUD","LU1670628061.USD","LU2097828714.EUR","LU0738911758.USD","LU2360106947.USD","LU2129689605.HKD","LU0348766576.USD","LU2211815571.USD","LU0965509010.AUD","SG9999001440.SGD","LU1923622614.USD","LU0395794307.EUR","LU1941712264.USD","IE00B1BXHZ80.USD","LU2778985437.USD","LU0316494557.USD","LU2237443382.USD","LU1720051017.SGD","LU0210536198.USD","IE00BLSP4239.USD","LLYX","LU0607220059.USD","LU0162691827.USD","LU1066051811.HKD","LU0072461881.USD","LU1794554557.SGD","IE00B775H168.HKD","LU2237443465.HKD","IE0009355771.USD","SG9999014914.USD","LU1917777945.USD","SG9999001176.USD","LU1720050803.USD","OZEM","LU1037948541.HKD","LU0868494708.USD","LU1267930490.SGD","LU0471298777.SGD","01276","LU1244550221.USD","LU1868836591.USD","BK1191","LU0354030511.USD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2324357040.USD","01801","LLYZ","LU0124676726.USD","LU1280957306.USD","LU1580142542.USD","IE0000B7K699.USD","LU2129689514.USD","SG9999002224.SGD","SG9999014567.USD","LU0265550946.USD","SGXZ31699556.SGD","LU2087625088.SGD","IE00BJJMRX11.SGD","LU0326950275.SGD","SGXZ99366536.SGD","LU0689626769.HKD","LU1064131003.USD","LU1718418525.SGD","LU1997244956.HKD","LU2242644610.SGD","LU0098860793.USD","SG9999014906.USD","LU2213496289.HKD","LU2461242641.AUD","LU1236620750.USD","FTXH","IE00B5MMRT66.SGD","MEDX","TBXU","LU0980610538.SGD","CURE","LU0198837287.USD","LU0265550359.USD","XLV","IXJ","BMY","SG9999015978.USD","JDOC","LU2097828805.USD","SG9999014542.SGD","GLAM","LU1883839398.USD","RXL","LU0553294199.USD","LU0795875169.SGD","SG9999014898.SGD","SG9999011175.SGD","LU2357305700.SGD","IBB","LU0648001328.SGD","LU1894683264.USD","LU0502904849.HKD","LU1979441026.SGD","LU1066053197.SGD","LU0471298694.HKD","LU0170899867.USD","LU1064130708.USD","LU2756315664.SGD","LU0320765489.SGD","BK0028","LU1074936037.SGD","LU0070302665.USD","600276","LU0820561818.USD","LU2089283258.USD","LU1003077747.HKD","KURE","IE000BZT7R73.USD","LU0238689110.USD","IE0001KFT4U8.USD","BMED","IE00BJLML261.HKD","BK4588","LU2362541513.USD","LU1989772840.SGD","LU0787776722.HKD","LU0225284248.USD","PJP","LU2125909593.SGD","LU0256863902.USD","SG9999018857.SGD","SGXZ81514606.USD","LU0109394709.USD","LU0545039389.USD","BK4139","LU0353189680.USD","01530","LU2471134523.USD","LU2552382132.HKD","LU0128525929.USD","BK4599","LU0405327494.USD","LU1267930730.SGD","IE000WAW04H5.SGD","LU0965509101.SGD","LU0477156953.USD","LU1061106388.HKD","LU0106261372.USD","LU0234572021.USD","LU1551013425.SGD","MRK","LU1232071149.USD","LU0455707207.USD","LU2125909247.SGD","LU2357627491.SGD","LU0211328371.USD","LU0345770308.USD","LU1116320901.HKD","LU1670710588.SGD","LU1934455277.USD","LU2468319806.SGD","LU1162221912.USD","LU2097828557.USD","IE00BFXG1179.USD","LU0149534421.HKD","SGXZ57979304.SGD","LU2476274720.SGD","AGNG","LU0348735423.USD","THNR","LU0348827113.USD","LU0708994859.HKD","LU0965509283.SGD","LU2237438978.USD","LU2111349929.HKD","LU2237443549.SGD","LU0310800379.SGD","LU1894683348.USD","LU0203202063.USD","LU1781817850.SGD","LU0466842654.USD","LU1989771016.USD","LU0661504455.SGD","LU0203345920.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU1623119135.USD","LU0208291251.USD","LU0320765059.SGD","LU0069063385.USD","HRTS","LU1145028129.USD","LU1261432733.SGD","LU1831875114.USD","LU1551013342.USD","LU0244354667.USD","IE00B2B36J28.USD","LU0540923850.HKD","LU1057294990.SGD","LU1035773651.USD","LU0882574139.USD","REGN","LU1037948897.HKD","IE00BSNM7G36.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1032466523.USD","LU2089284900.SGD","IE00BFSS7M15.SGD","LU0158827948.USD","LU1655091616.SGD","LU2495084118.USD","LU0289739343.SGD","IE00BLSP4452.SGD","ABBV","LU0109391861.USD","LU2347655073.USD","LU1548497426.USD","LU1989772923.USD","LU0689472784.USD","LU1804176565.USD","LU2552382058.USD","LU0561508036.HKD","IE00B19Z3581.USD","LU0130517989.USD","LU0985320562.USD","IE00B543WZ88.USD","BK1583","BK0012","LU1712237335.SGD","LU1691799644.USD","LU2596442595.SGD","LU2242652126.USD","IE00BVYPNV92.GBP","LU2023251221.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","LU0029864427.USD","SG9999015341.SGD","LU1023059063.AUD","IE00B42XCP33.USD","LU2602419157.SGD","SG9999014559.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670399962","title":"科迪亚克科学公司股价上涨，因其眼部疾病药物达到临床试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2670399962","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670399962?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592647,"startTime":"0","endTime":"0","summary":"BUZZ-科迪亚克科学公司股价上涨，因其眼部疾病药物达到临床试验目标9月28日-** 制药公司科迪亚克科学（Kodiak Sciences，股票代码：KOD.O）的股价在盘前交易中上涨43.9%，至46.56美元** 该公司表示，其实验性药物Zenkuda和tabirafusp-ted在针对湿性年龄相关性黄斑变性患者开展的晚期临床试验中达到了主要目标** 这两种药物在一年时均实现了视力改善，其效果","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4T45K0PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","IBB","LU0823416689.USD","LU0823434740.USD","BBH","LU1917777945.USD","KOD","LU2362541273.HKD","LU0114720955.EUR","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","LU0053666078.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","LU0058720904.USD","LU0289739699.SGD","IBBQ","LU2023250504.SGD","LU0889565916.HKD","LU0320765992.SGD","REGN","BK4505","BK4585","LU2237438978.USD","LU0823434583.USD","BK4139","LU1974910355.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670233174","title":"正大天晴与STADA达成生物类似药战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2670233174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670233174?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 17:33","pubTimestamp":1790587999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1992135399.USD","LU2272731782.SGD","PPH","LU2322448957.HKD","LU2473716301.USD","IE00B5TLWC47.USD","XPH","LU1992135472.HKD","LU2272731600.USD","BK4588","LU2272731865.HKD","LU2322448791.USD","BK4585","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670023840","title":"罗氏：公司整理的分析师共识显示，预计到2030年生物类似药将造成62亿瑞士法郎的销售缺口。","url":"https://stock-news.laohu8.com/highlight/detail?id=2670023840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670023840?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 17:07","pubTimestamp":1790586449,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1992135399.USD","LU2272731600.USD","BK4585","PPH","LU2272731782.SGD","BK4588","LU2272731865.HKD","LU2322448791.USD","IE00B5TLWC47.USD","FXF","IBB","LU1992135472.HKD","LU2473716301.USD","XPH","LU2322448957.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421598","title":"美国食品药品监督管理局批准Mirum公司治疗罕见骨病的药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421598","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421598?lang=zh_cn&edition=fundamental","pubTime":"2026-09-26 02:57","pubTimestamp":1790362678,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局批准Mirum公司治疗罕见骨病的药物路透9月25日-美国食品药品监督管理局周五表示，已批准米鲁姆制药公司（Mirum Pharmaceuticals）的MIRM.O药物用于治疗一种罕见骨病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4T45H12U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","LU2362541513.USD","MIRM","LU2106854487.HKD","LU2089984988.USD","BK4585","BK4588","LU2362541273.HKD","LU0889565916.HKD","REGN","BBH","LU0109394709.USD","LU1974910355.USD","INCY","LU0053666078.USD","LU0823434583.USD","IBBQ","LU0114720955.EUR","LU2468319806.SGD","IBB","LU2023250504.SGD","LU2362540622.SGD","IDNA","BK4532","BK4139","BK4550","LU0289739699.SGD","LU0320765992.SGD","LU0823416689.USD","LU0882574055.USD","LU0058720904.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670824413","title":"健康快讯：基因研究成果为逆转阿尔茨海默病脑损伤提供了线索","url":"https://stock-news.laohu8.com/highlight/detail?id=2670824413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670824413?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 04:51","pubTimestamp":1790283102,"startTime":"0","endTime":"0","summary":"健康快讯：基因研究成果为逆转阿尔茨海默病脑损伤提供了线索《Health Rounds》荣获2026年出版商通讯奖“最佳科学通讯”奖，每周二和周四发布。阿尔茨海默病相关基因的影响或可逆转研究阿尔茨海默病最强遗传风险因素的科学家表示，他们发现了关于该基因作用机制的新线索，并指出其对大脑的损害效应或许有可能被逆转。I期临床试验旨在评估安全性而非疗效，因此这一令人鼓舞的结果尚需通过更大规模的试验予以证实。该研究以小鼠细胞为对象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4T45G1QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IBB","LU0889565916.HKD","LU1674673428.USD","LU1066053197.SGD","LU0861579265.USD","LU1934455277.USD","LU0114720955.EUR","LU2468319806.SGD","BK4532","LU1057294990.SGD","LU1571399168.USD","BBH","LU1430594728.SGD","MEDI","LU1778281490.HKD","TBXU","IE00BZ1G4Q59.USD","LU0823416689.USD","GILD","LU0965508806.USD","LU0965509010.AUD","LU1934455194.USD","IE00B3T34201.USD","LU0965509283.SGD","LU0234570918.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","IE0002270589.USD","BK4566","LU0965509101.SGD","LU1023059063.AUD","SG9999015986.USD","SG9999015978.USD","LU2087621335.USD","LU0122379950.USD","IBBQ","SG9999015945.SGD","BMED","LU1934455863.HKD","LU1674673691.USD","BIB","LU1061106388.HKD","BK4588","LU0320765992.SGD","LU0289739699.SGD","SG9999015952.SGD","TMED","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669453169","title":"安进一种自身免疫药物在后期临床试验达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2669453169","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669453169?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 10:32","pubTimestamp":1790217159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","PJP","PSYK","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4581","IBBQ","BK4534","IE0002141913.USD","PBE","LU0109394709.USD","MDTX","BIB","IBBJ","BBH","LU2089984988.USD","IBB","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","IE0009355771.USD","SG9999001440.SGD","LU2242646821.SGD","BK4599","LU0122379950.USD","LU0868494617.USD","LU0289739699.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","BMED","BK4533","BK4585","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","AMGN","LU1023059063.AUD","TBXU","LU0889565916.HKD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669643959","title":"美国法官在夏威夷能源和解协议争议中主动回避","url":"https://stock-news.laohu8.com/highlight/detail?id=2669643959","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669643959?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 05:01","pubTimestamp":1790197315,"startTime":"0","endTime":"0","summary":"美国法官在夏威夷能源和解协议争议中主动回避法官表示，他及其家人可能受此前和解协议的保护法院委员会向该法官提供了伦理指导一名来自俄勒冈州的法官被指定主持该诉讼Mike Scarcella路透9月23日-夏威夷一名联邦法官已主动回避审理一起争议案件，该案涉及数十年前达成的价格垄断和解协议是否阻止该州就气候变化问题起诉雪佛龙及其他能源公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4S45F1FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IBB","LU2133065610.SGD","VDE","XLE","BBH","LU0640476718.USD","LU0070302665.USD","DIG","GXPE","FTXN","LU0265550359.USD","LU0114720955.EUR","LU0109394709.USD","LU0149725797.USD","LU0256331488.USD","BMED","LU1929549753.HKD","IXC","LU0345780950.USD","LU1162221912.USD","LU2168564149.EUR","CVX","GILD","IE00B2Q91V27.USD","LU1032466523.USD","LU0965509283.SGD","TBXU","ERX","DRLL","TMED","LU0868494708.USD","LU1934455863.HKD","IBBQ","FENY","LU0320765992.SGD","IYE","TEXU","IGE","LU0942090050.USD","LU0630314457.HKD","LU1430597077.USD","MEDI","TRUN","LU1674673428.USD","IE00BZ1G4Q59.USD","LU0788109394.HKD","BK4534","WEEI","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669059271","title":"美国研究综述-Allstate、Autozone、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669059271","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669059271?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 15:38","pubTimestamp":1790149088,"startTime":"0","endTime":"0","summary":"美国研究综述-Allstate、Autozone、Vertex Pharmaceuticals路透9月23日-周三，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括Allstate、Autozone和Vertex Pharmaceuticals。股票条目按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4S45F0H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU2089985449.USD","LU0187121727.USD","LU1585245621.USD","LU1069347547.HKD","LU2380233275.USD","LU1057294990.SGD","LU1815336760.USD","IBBQ","LU1261432733.SGD","LU1699723380.USD","LU0061475181.USD","LU2242652126.USD","LU0256863811.USD","LU1093756168.USD","PATH","LU0266013472.USD","LU0274383776.USD","IE0009355771.USD","BK4141","LU2125154778.USD","LU1934455277.USD","LU2543165471.USD","IE00BBT3K403.USD","LU2298322129.HKD","MRVX","IE000M9KFDE8.USD","LU1989764748.USD","PPH","LU0289739343.SGD","LU0162691827.USD","BK4539","LU0238689110.USD","LU1720051108.HKD","LU2125154935.USD","LU2322448791.USD","LU0963586101.USD","LU1201861249.SGD","BK4532","LU1119994496.HKD","MRK","LU1116320901.HKD","LU0889565916.HKD","IE00BN8TJ469.HKD","VMC","SG9999000418.SGD","LU1861558580.USD","LU0300736492.USD","IE00BMPRXR70.SGD","LU1989764664.SGD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0069063385.USD","LU2098885051.SGD","BK4139","DCH","LU0057025933.USD","IE0004086264.USD","IE0000B7K699.USD","LU0154245756.USD","IE00BLSP4452.SGD","LU0320765992.SGD","LU0861579265.USD","LU0265550359.USD","LU0154245673.USD","OZEM","LU1023059063.AUD","SG9999014559.SGD","LU1989771016.USD","LU2322448957.HKD","LU1559883803.SGD","LU0965509283.SGD","LU0724618433.USD","LU1878469433.USD","LU1983299246.USD","LU0950375773.USD","BK4599","ON","BK4551","LU1861219969.SGD","LU0053666078.USD","LU2362541513.USD","SGXZ57979304.SGD","GNMX","LU1162221912.USD","LU0444973449.USD","BK4588","LU2458330243.SGD","LU0823416689.USD","BK4517","LU2290526834.HKD","LU0056508442.USD","VHT","LU1992135399.USD","IE00B1BXHZ80.USD","LU0124384867.USD","BK4548","LU1989772840.SGD","MADE","FAI","LU1196500208.SGD","LU0130102774.USD","LU0868494617.USD","BK4136","BK4142","LU2491050071.SGD","LU2491049909.HKD","IE00B19Z9P08.USD","LU0072461881.USD","LU1720051017.SGD","LU2491050154.USD","LU1823568750.SGD","LU0314106906.USD","MRVU","BK4128","LU0823434583.USD","BK4559","AIS","LU0320765646.SGD","LU2506952097.USD","LU0289961442.SGD","SITM","SG9999013999.USD","LU0980610538.SGD","LU1037948897.HKD","LU2106854487.HKD","IE00B894F039.SGD","MRVL","LU1066051498.USD","LU0300736062.USD","IE000WAW04H5.SGD","BK4515","LU0098860793.USD","LU0471298694.HKD","BK4547","LU1035773651.USD","IE000F7OJYX1.SGD","IBB","IE00BZ9MQY76.HKD","LU0942090050.USD","BK4007","LU1069344957.HKD","LU0205194284.USD","LU0385154629.USD","LU2360106947.USD","VKTX","LU2357627491.SGD","RXL","SG9999002224.SGD","LU2362541273.HKD","BK4097","LU1221951046.USD","LU0081259029.USD","LU2244417387.USD","BK4567","LU0823417653.USD","LU1642822529.SGD","BK4566","LU0124676726.USD","ANIX","LU2462157665.USD","BK4505","LU2361045086.USD","BK4011","IE00B19Z3B42.SGD","LU0823421333.USD","LU0868494708.USD","ONX","LU0476273544.USD","LU2360107168.USD","LU2324357040.USD","FTXL","IE00BMPRXQ63.HKD","LU0234572021.USD","BK4605","LU0203345920.USD","SMHX","LU1061106388.HKD","SG9999015358.SGD","SG9999001440.SGD","PJP","LU1721429741.USD","LU2360032135.SGD","BK4211","LU0432979614.USD","LU1303367103.USD","LU0208291251.USD","LU1861220033.SGD","LU2272731865.HKD","SG9999001077.SGD","LU1978683503.SGD","LU2237438978.USD","LU1941712348.USD","FTXH","SOXY","IE000SO60NU8.SGD","IE0002141913.USD","BK4107","LU0472753341.HKD","IE00B2B36J28.USD","LU1093756325.SGD","FDTX","LU2360107325.USD","MLM","SITX","ACHC","BK4516","FXL","IE00B3S45H60.SGD","BK4088","LU0234570918.USD","LU0127658192.USD","LU2506951875.HKD","LU1169589451.USD","SMTC","LU1316542783.SGD","LU0642271901.SGD","IE00B19Z9Z06.USD","SG9999014542.SGD","BK4550","IE00BZ199S13.USD","LU0070302665.USD","CLDX","LU1046421795.USD","LU0106261372.USD","LU1992135472.HKD","LU1674673691.USD","LU1934455863.HKD","BK4581","LU0058720904.USD","LU2092937221.SGD","BMED","IE0002270589.USD","HRTS","GTEK","LU1923622614.USD","SG9999001176.USD","LU1778281490.HKD","XLV","SG9999001176.SGD","LU2272731600.USD","LU1861215975.USD","XHB","AIFD","BIB","04332","LU1221951129.SGD","GPK","IE00B4R5TH58.HKD","LU0965509101.SGD","IHE","LU2023250504.SGD","LU0859254822.USD","LU1974910355.USD","LU0154236417.USD","LU2931357623.SGD","VRTX","BK4533","GDOC","WUGI","QQQA","LU2298321311.HKD","IE00BMPRXN33.USD","LU1941712264.USD","LU1032466523.USD","LU2361044949.HKD","AZO","BK4149","LU1721429402.USD","AMGN","LU0211331839.USD","DTCR","IYH","LU0122379950.USD","LU1116320737.USD","LU2463526074.USD","LU1548497426.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU2357305700.SGD","LU1066053197.SGD","TRUH","IE000BZT7R73.USD","JDOC","LU1861214812.USD","LU0823434740.USD","BK4534","LU1235294995.USD","LU1989772923.USD","IE00B19Z3581.USD","LU2125909247.SGD","LU2461242641.AUD","LU0957808578.USD","BBH","LU0345770993.USD","LU2360108059.USD","BSVN","LU1983260115.SGD","LU0320765489.SGD","LU1861559042.SGD","LU0511384066.AUD","LU0106261612.USD","KBH","ANAB","PAWZ","ARTY","GRDN","LU0823417737.USD","LU1066051225.USD","LU0130517989.USD","FHLC","LU2468319806.SGD","IXJ","BK4185","LU2272731782.SGD","IE000MB6IJN5.SGD","LU0345770308.USD","BK4604","LU2112291526.USD","LU2125909593.SGD","LU1917777945.USD","LU1854104046.USD","LU0566484027.USD","LU2473716301.USD","LU2433249047.HKD","LU1084165304.USD","BK4099","LU0289739699.SGD","LU1934455194.USD","IDNA","THO","SG9999002232.USD","LU2065732104.USD","LU1169590202.USD","CMI","CMPX","LU0786609619.USD","LU2041044095.USD","LU1674673428.USD","SG9999015341.SGD","LU1852331112.SGD","XNTK","LU0079474960.USD","LU0965509010.AUD","LU2362540622.SGD","SMTG","IE00BFMHRM44.USD","LU1430594728.SGD","LU0985320562.USD","IE00BLSP4239.USD","LU1032955483.USD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU0012050646.USD","LU0823421416.USD","LU1035775433.USD","LU0348723411.USD","LU2361044865.SGD","MVLL","LU0471298777.SGD","IE00BD6J9T35.USD","LU0689626769.HKD","PKB","LU2355687059.USD","LU0203347892.USD","LU1854103824.USD","LU2506952170.USD","BK4561","IE0004091025.USD","LU1066051811.HKD","LU2242646821.SGD","LU1506573853.SGD","ONG","PBE","LU2458330169.SGD","LU2456880835.USD","LU2506951958.HKD","LU0205193047.USD","LU0265550946.USD","CCL","LU1571399168.USD","BK4585","SG9999014575.USD","LU0444971666.USD","SG9999014567.USD","ALL","BK4543","BK4124","LU0477156953.USD","LU0006306889.USD","BK4512","THNR","LU0417517546.SGD","LU2236285917.USD","BK4196","IAK","TBXU","LU1037948541.HKD","PATX","IE00B775SV38.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU2417539215.USD","BK4214","LU2023250843.SGD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669182123","title":"安进(AMGN)股票9月22日盘中上涨3.90%：原因全解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2669182123","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669182123?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 23:16","pubTimestamp":1790090164,"startTime":"0","endTime":"0","summary":"• 在 dazodalibep 的 3 期 OASIZ 301 试验取得积极结果后，安进股价上涨。\n• 公司公布的年营收为 367.5 亿美元，净利润为 77.1 亿美元。\n• 分析师给出的平均目标价为 389.14 美元，评级为“持有”。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262180817-market-movers-amgn-20260922","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4585","AMGN","BK4534","LU1023059063.AUD","LU0122379950.USD","TBXU","IE00BJT1NW94.SGD","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IBB","BK4599","LU2468319806.SGD","LU1983299246.USD","LU2242646821.SGD","LU1061106388.HKD","LU2089984988.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","PJP","IE0009355771.USD","PBE","BBH","LU2112291526.USD","LU1057294990.SGD","LU0889565916.HKD","LU0289739699.SGD","BK4533","LU0868494617.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU1571399168.USD","BK4566","LU2242652126.USD","BK4139","LU0058720904.USD","IE00BJJMRZ35.SGD","IBBQ","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121969920","title":"安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121969920","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121969920?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:50","pubTimestamp":1790085037,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——安进公司（Amgen Inc）于近日披露其关键临床进展：\n安进旗下药物Dazodalibep在针对中重度症状性干燥综合征的III期OASIZ 303研究中，成功达到主要终点，该项试验预计将于2026年第四季度完成。\n安进表示，Dazodalibep在III期干燥综合征试验中取得主要终点的积极结果，该药物在系统性疾活动度方面展现出具有统计学显著性及临床意义的改善。\n值得注意的是，这一进展为干燥综合征患者群体带来了新的治疗希望。安进公司股票代码为AMGN.O。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1061106388.HKD","BK4585","AMGN","LU0058720904.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4581","BK4139","BK4533","LU2242646821.SGD","BBH","SG9999001440.SGD","TBXU","BK4534","BK4588","LU0889565916.HKD","LU1571399168.USD","LU0868494617.USD","LU0320765992.SGD","BK4566","PBE","PJP","LU2112291526.USD","IE0002141913.USD","BIB","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0109394709.USD","LU2242652126.USD","LU0289739699.SGD","LU2089984988.USD","BK4599","IE0009355771.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669019147","title":"安进股价上涨，因其自身免疫疾病药物达到晚期临床试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2669019147","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669019147?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:48","pubTimestamp":1790084914,"startTime":"0","endTime":"0","summary":"BUZZ-安进股价上涨，因其自身免疫疾病药物达到晚期临床试验目标9月22日-** 制药公司安进（Amgen）AMGN.O的股价上涨2.4%，至402.69美元** 该公司表示，其用于治疗舍格伦综合征的实验性药物达佐达利贝普（dazodalibep）在后期临床试验中达到了降低疾病活动度的主要目标 (link)** 舍格伦综合征是一种自身免疫性疾病，会导致眼睛、口腔及身体其他部位干燥，并伴有疲劳和慢性疼痛** 该药物在第48周时显示出具有统计学意义且临床意义显著的改善；大多数副作用为轻度至中度** 该公司计划在即将举行的医学会议上公布详细结果** 计入本次交易，AMGN今年以来累计上涨23.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4T45E0WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4534","BBH","IBBQ","IE00B2B36J28.USD","LU2242646821.SGD","LU0122379950.USD","PBE","BK4139","IE00BJJMRZ35.SGD","LU2112291526.USD","IBB","BK4588","LU1061106388.HKD","SG9999001440.SGD","TBXU","IE0002141913.USD","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU2242652126.USD","BK4581","PJP","IE0009355771.USD","BK4599","BIB","LU1571399168.USD","LU1983299246.USD","LU0868494617.USD","LU1023059063.AUD","LU2089984988.USD","LU0289739699.SGD","LU2468319806.SGD","LU1057294990.SGD","BK4566","IE00B4R5TH58.HKD","AMGN","BK4533","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147201","title":"Vertex股价上涨，因其肾病药物在中期研究中展现出良好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147201","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147201?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:40","pubTimestamp":1790084435,"startTime":"0","endTime":"0","summary":"BUZZ-Vertex股价上涨，因其肾病药物在中期研究中展现出良好前景9月22日-** Vertex Pharmaceuticals（VRTX.O）股价上涨1.1%，至516.53美元** 这家生物技术公司表示，其试验性药物 inaxaplin 在治疗 APOL1 介导的肾病患者 13 周后，使尿液中蛋白质含量（肾损伤的关键指标）降低了 42.7%** 这种遗传性肾脏疾病主要影响非洲裔人群，可能导","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4T45E0WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU2362541513.USD","IE00BJT1NW94.SGD","LU1035775433.USD","IBBQ","GNMX","PBE","IE00B19Z3581.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00B19Z9P08.USD","BIB","BBH","LU2362541273.HKD","LU2089984988.USD","IBB","IE00BZ9MQY76.HKD","LU2456880835.USD","IE0002270589.USD","IE00B2B36J28.USD","LU1093756168.USD","LU1069344957.HKD","BK4588","LU2236285917.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","IE0009355771.USD","IE00B19Z9Z06.USD","LU1674673428.USD","VRTX","LU0432979614.USD","LU2324357040.USD","LU1430594728.SGD","BK4532","IE00B4R5TH58.HKD","LU2362540622.SGD","BK4533","BK4585","BK4567","SG9999001176.SGD","LU1778281490.HKD","SG9999001176.USD","SGXZ57979304.SGD","LU2462157665.USD","LU2237438978.USD","LU0061475181.USD","TBXU","LU0889565916.HKD","SG9999013999.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142742","title":"数据简报-随着竞争日趋激烈，减肥药开发商纷纷抢占这一利润丰厚的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142742","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142742?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:09","pubTimestamp":1790082578,"startTime":"0","endTime":"0","summary":"数据简报-随着竞争日趋激烈，减肥药开发商纷纷抢占这一利润丰厚的市场更新发稿日期，补充罗氏和Viking Therapeutics提供的最新减肥药临床试验数据路透9月22日-减肥药市场正蓬勃发展，生物技术公司竞相争夺这一由诺和诺德和礼来主导的快速增长领域的市场份额。在其中一项试验中，该药物帮助超重患者减重22.7%，低于诺和诺德25%的预期。辉瑞表示，其目标是在2028年获得快速增长的减肥药市场中的首次批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4S45E0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAWZ","IBBQ","LLYZ","ELIL","GDOC","BIB","AMGN","IBRN","KLRA","SRRK","ALT","VHT","WDNA","00016","GPCR","OZEM","HRTS","FHLC","THNR","01093","03692","03145","OPK","TRUH","FTXH","PFE","KURE","AZN.UK","LLYX","IBB","80016","PPH","TBXU","MEDX","CURE","JDOC","CANC","LLII","LLY","MRK","VKTX","SUHJY","03933","IXJ","BBH","MTSR","03121","02105","AGNG","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114208","title":"安进股价盘前大涨逾4%，受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669114208?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AZNH","MRNX","PJP","GNOM","PBPH","BBH","RXL","LFSC","IEIH","BIB","PPH","WDNA","XPH","RSPH","TMED","TBXU","BK4599","MEDI","BIOY","BME","IBRN","MRNY","LU0320765992.SGD","BBP","FTXH","BK4585","FBT","IDNA","IE00B5TLWC47.USD","LU0109394709.USD","LU2242646821.SGD","AMGN","IE00B4R5TH58.HKD","IEHS","LU0058720904.USD","LU0122379950.USD","SYNB","CANC","LU2473716301.USD","SBIO","IBBQ","PBE","PSCH","IYH","LU1992135472.HKD","LU2272731782.SGD","XBIX","HELX","LU2272731865.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198157419","title":"福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果，第13周UACR显著降低42.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198157419","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198157419?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082369,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——福泰制药 今日发布重大公告，披露其在APOL1介导肾病额外患者群体中开展的2b期AMPLIFIED研究取得积极成果。详细数据显示，对于伴有中度蛋白尿的AMKD患者，Inaxaplin在治疗第13周时使尿白蛋白肌酐比较基线下降了42.7%。两项研究队列均显示，Inaxaplin总体安全性和耐受性良好，未出现意外安全信号。值得注意的是，这是福泰制药在这两个特定亚群中首次公布Inaxaplin的临床数据，进一步拓展了该药物在AMKD治疗领域的潜在应用范围。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU0256863811.USD","GNMX","TBXU","LU1585245621.USD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE00BZ9MQY76.HKD","LU1035775433.USD","LU2362541513.USD","LU0079474960.USD","PBE","SG9999013999.USD","SGXZ57979304.SGD","LU2089984988.USD","LU2362540622.SGD","LU1430594728.SGD","LU2417539215.USD","LU0417517546.SGD","IE0009355771.USD","IE0002270589.USD","BK4533","BK4567","BK4585","LU1093756325.SGD","LU2462157665.USD","BK4139","IE00BFTCPJ56.SGD","IBBQ","BIB","LU0320765992.SGD","IE00B19Z9P08.USD","LU0823416689.USD","BK4532","LU0289739699.SGD","LU0889565916.HKD","VRTX","LU0234570918.USD","LU1674673428.USD","LU1778281490.HKD","SG9999001176.USD","IDNA","IE00BJJMRZ35.SGD","LU1069344957.HKD","LU2456880835.USD","IBB","LU0058720904.USD","LU2236285917.USD","BK4588","LU2362541273.HKD","LU0432979614.USD","LU1093756168.USD","LU2324357040.USD","SG9999001176.SGD","BBH","IE0002141913.USD","LU2237438978.USD","IE00B2B36J28.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU1674673691.USD","IE00B894F039.SGD","IE00B19Z3581.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167058424","title":"安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167058424","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167058424?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082253,"startTime":"0","endTime":"0","summary":"安进公司今日发布重磅消息：其研发的Dazodalibep在针对中重度系统性干燥综合征的3期临床试验中，交出了一份令人振奋的答卷。这项研究聚焦于那些饱受病痛折磨的患者群体，而试验数据无疑为这片治疗荒漠带来了希望的甘霖。结果显示，与安慰剂组相比，接受Dazodalibep治疗的患者在关键疗效指标上均实现了统计学意义上的显著改善。分析人士指出，该药物的成功若能在后续环节得以延续，其市场潜力不容小觑，或将重新定义干燥综合征的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0868494617.USD","LU0058720904.USD","LU0109394709.USD","BK4139","IE00B2B36J28.USD","BK4585","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4599","BK4581","LU1983299246.USD","AMGN","SG9999001440.SGD","BK4588","IE0002141913.USD","LU1061106388.HKD","LU2468319806.SGD","TBXU","BK4533","LU1023059063.AUD","LU2112291526.USD","LU2089984988.USD","PJP","BIB","IBB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0122379950.USD","LU1571399168.USD","BK4566","IBBQ","IE0009355771.USD","LU0289739699.SGD","LU0889565916.HKD","PBE","LU2242652126.USD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196869155","title":"安进：Dazodalibep在系统性疾病活动方面展现出统计学显著且具有临床意义的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1196869155","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196869155?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:01","pubTimestamp":1790082073,"startTime":"0","endTime":"0","summary":"安进公司宣布，其实验性药物Dazodalibep在治疗中取得了重大突破。最新研究数据显示，该药物在改善系统性疾病活动方面，不仅达到了统计学上的显著效果，更在临床实践中展现出切实的改善意义。\n这一积极结果无疑为患者群体带来了新的希望，同时也为安进在竞争激烈的医药研发领域增添了重要砝码。相关研究的具体数据与详细分析，预计将在后续的医学会议或学术期刊中进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0122379950.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","BIB","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","PJP","IE00BJJMRZ35.SGD","BK4581","LU2112291526.USD","IE0009355771.USD","BK4585","LU0109394709.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","LU2242652126.USD","IBBQ","LU0868494617.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669014292","title":"更正-安进的自身免疫性疾病药物在后期临床试验中取得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2669014292","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669014292?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082024,"startTime":"0","endTime":"0","summary":"更正-安进的自身免疫性疾病药物在后期临床试验中取得成功更正上一条要点，说明该药物的另一项晚期临床试验预计将于第四季度完成路透9月22日-安进公司周二表示，其用于治疗一种攻击人体分泌液腺体的自身免疫性疾病的实验性药物，在晚期临床试验中达到了降低疾病活动度的主要目标。安进公司表示，试验中出现的大多数不良事件均为轻度至中度，仅有少数患者中止了治疗。安进计划在即将举行的医学会议上公布该试验的详细数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4T45E0UA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","IBBQ","JNJ","RXL","IE00B1BXHZ80.USD","LU1496350502.SGD","LU1023059063.AUD","TRUH","LU1551013425.SGD","BK4585","LU0689626769.HKD","AMGN","LU1162221912.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","IE00B42XCP33.USD","SG9999002224.SGD","BMED","LU1674673428.USD","IE00BLSP4452.SGD","IXJ","LU0738911758.USD","LU1894683264.USD","SG9999013999.USD","BBH","LU1066051498.USD","LU1066053197.SGD","LU1244550221.USD","LU0640476718.USD","TBXU","FTXH","LU0661504455.SGD","BK4588","FHLC","XLV","PJP","PBE","IYH","JDOC","LU2430703178.SGD","VHT","LU2133065610.SGD","BIB","LU0114720955.EUR","LU1221951129.SGD","IHE","MEDX","LU0820562030.AUD","LU2236285917.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}